Jordan Daily – Dr. Ismail Shehada, Chief Executive Officer of Tabuk Pharmaceuticals Manufacturing Company, has been awarded the Best CEO Award -Pharmaceutical at the GBO Awards 2025, recognizing his leadership and the company’s growing role in the regional pharmaceutical industry.
The award reflects a series of milestones achieved by Tabuk Pharmaceuticals, highlighting its expanding presence and continued contribution to advancing pharmaceutical manufacturing and innovation, the company said in a statement seen by Jordan Daily.
In remarks following the announcement, Shehada said the recognition belonged to the entire Tabuk Pharmaceuticals team rather than to him personally, citing their collective dedication, innovation, and commitment to excellence.
“Our journey has always been defined by a simple goal: advancing the pharmaceutical industry and delivering excellence without compromise,” Shehada said, adding that the award would serve as motivation to set higher benchmarks in the future.
Shehada also thanked the organizers of the GBO Awards, as well as colleagues and partners, for their continued support.
